OPA
NVS icon

Old Port Advisors’s Novartis NVS Stock Holding History

Old Port Advisors’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.33M Buy
21,266
+165
+0.8% +$24.7K 0.66% 36
2026
Q1 		$3.22M Buy
21,101
+109
+0.5% +$16.7K 0.74% 36
2025
Q4 		$2.89M Buy
20,992
+291
+1% +$38.1K 0.71% 43
2025
Q3 		$2.65M Buy
20,701
+295
+1% +$36K 0.67% 45
2025
Q2 		$2.47M Buy
20,406
+1,144
+6% +$129K 0.67% 44
2025
Q1 		$2.15M Sell
19,262
-284
-1% -$30.2K 0.64% 56
2024
Q4 		$1.9M Sell
19,546
-31
-0.2% -$3.31K 0.55% 61
2024
Q3 		$2.25M Sell
19,577
-267
-1% -$30.3K 0.63% 55
2024
Q2 		$2.11M Sell
19,844
-114
-0.6% -$11.4K 0.63% 55
2024
Q1 		$1.93M Buy
19,958
+142
+0.7% +$14.6K 0.59% 57
2023
Q4 		$2M Buy
19,816
+479
+2% +$46.2K 0.66% 53
2023
Q3 		$1.97M Buy
+19,337
New +$1.96M 0.71% 50
2023
Q1 		$1.84M Buy
19,165
+1,135
+6% +$99.1K 0.66% 52
2022
Q4 		$1.64M Buy
18,030
+886
+5% +$74.6K 0.62% 55
2022
Q3 		$1.33M Buy
17,144
+683
+4% +$56.6K 0.53% 67
2022
Q2 		$1.39M Buy
16,461
+844
+5% +$74K 0.54% 60
2022
Q1 		$1.37M Buy
15,617
+831
+6% +$71.9K 0.47% 74
2021
Q4 		$1.3M Buy
14,786
+541
+4% +$44.9K 0.44% 78
2021
Q3 		$1.17M Buy
14,245
+2,256
+19% +$203K 0.42% 74
2021
Q2 		$1.11M Buy
11,989
+6,231
+108% +$555K 0.4% 73
2021
Q1 		$492K Buy
5,758
+1,445
+34% +$130K 0.19% 121
2020
Q4 		$407K Buy
4,313
+538
+14% +$47K 0.18% 125
2020
Q3 		$328K Sell
3,775
-950
-20% -$82.3K 0.16% 126
2020
Q2 		$413K Buy
4,725
+425
+10% +$36.7K 0.22% 108
2020
Q1 		$355K Buy
4,300
+1,189
+38% +$106K 0.22% 101
2019
Q4 		$297K Buy
3,111
+389
+14% +$34.9K 0.14% 138
2019
Q3 		$234K Hold
2,722
– – 0.12% 152
2019
Q2 		$252K Sell
2,722
-186
-6% -$15.7K 0.13% 150
2019
Q1 		$251K Buy
2,908
+49
+2% +$3.93K 0.13% 152
2018
Q4 		$226K Buy
+2,859
New +$223K 0.13% 152

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Old Port Advisors's NVS Position: Q2 2026 in Review

Old Port Advisors increased its Novartis (NVS) stake by 0.78% in Q2 2026, buying an estimated $24.7K and bringing the position to 21,266 shares worth $3.33M. The position accounts for 0.66% of the portfolio, ranked #36.

Old Port Advisors first reported a position in NVS in Q4 2018 and has held it in 30 quarters since. 1,620 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Old Port Advisors held 21,266 shares of Novartis worth $3.33M as of Q2 2026.
  • Old Port Advisors bought 165 Novartis shares in Q2 2026, an estimated $24.7K.
  • Novartis made up 0.66% of Old Port Advisors's portfolio in Q2 2026, its #36 holding.
  • Old Port Advisors first reported a position in Novartis in Q4 2018 and has held it in 30 quarters since.
  • 1,620 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Old Port Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.